BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
- PMID: 8764100
BRCA1 is a 220-kDa nuclear phosphoprotein that is expressed and phosphorylated in a cell cycle-dependent manner
Erratum in
- Cancer Res 1996 Sep 1;56(17):4074
Abstract
Mouse polyclonal antibodies, raised against three regions of the human BRCA1 protein, were characterized and revealed BRCA1 as a 220-kDa nuclear phosphoprotein in normal cells. All three antisera recognize both in vitro-translated and recombinant, baculovirus-derived BRCA1, which co-migrate with BRCA1 from the human breast epithelia cell line, HBL100. BRCA1 expression and phosphorylation are shown to be cell cycle dependent, with greatest expression and phosphorylation occurring in S and M phases. Cyclin-dependent kinase 2 and other kinases associated with cyclins D and A are shown to bind to and phosphorylate BRCA1, suggesting that the biological activity of BRCA1 may be regulated by cyclin-dependent kinases.
Similar articles
-
BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.Oncogene. 1997 Jul 10;15(2):143-57. doi: 10.1038/sj.onc.1201252. Oncogene. 1997. PMID: 9244350
-
Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.Nat Cell Biol. 2000 Apr;2(4):232-9. doi: 10.1038/35008660. Nat Cell Biol. 2000. PMID: 10783242
-
The BRCT domain is a phospho-protein binding domain.Science. 2003 Oct 24;302(5645):639-42. doi: 10.1126/science.1088753. Science. 2003. PMID: 14576433
-
Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.Virology. 2000 Feb 15;267(2):335-49. doi: 10.1006/viro.1999.0147. Virology. 2000. PMID: 10662629
-
BRCA1 phosphorylation: biological consequences.Cancer Biol Ther. 2006 May;5(5):470-5. doi: 10.4161/cbt.5.5.2845. Epub 2006 May 30. Cancer Biol Ther. 2006. PMID: 16721040 Review.
Cited by
-
An estrogen receptor-alpha/p300 complex activates the BRCA-1 promoter at an AP-1 site that binds Jun/Fos transcription factors: repressive effects of p53 on BRCA-1 transcription.Neoplasia. 2005 Sep;7(9):873-82. doi: 10.1593/neo.05256. Neoplasia. 2005. PMID: 16229810 Free PMC article.
-
Localization of BRCA1 protein at the cellular level.J Mammary Gland Biol Neoplasia. 1998 Oct;3(4):423-9. doi: 10.1023/a:1018740216630. J Mammary Gland Biol Neoplasia. 1998. PMID: 10819536 Review.
-
BRCA1 the Versatile Defender: Molecular to Environmental Perspectives.Int J Mol Sci. 2023 Sep 19;24(18):14276. doi: 10.3390/ijms241814276. Int J Mol Sci. 2023. PMID: 37762577 Free PMC article. Review.
-
Differences in 53BP1 and BRCA1 regulation between cycling and non-cycling cells.Cell Cycle. 2013 Dec 1;12(23):3629-39. doi: 10.4161/cc.26582. Epub 2013 Oct 2. Cell Cycle. 2013. PMID: 24091731 Free PMC article.
-
Insulin-like growth factor receptor-1 (IGF-IR) as a target for prostate cancer therapy.Cancer Metastasis Rev. 2014 Sep;33(2-3):607-17. doi: 10.1007/s10555-013-9482-0. Cancer Metastasis Rev. 2014. PMID: 24414227 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Other Literature Sources
Molecular Biology Databases
Miscellaneous